Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Demetri

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Chest|June 1, 1995
Hematopoietic growth factors. Defining the appropriate clinical role in multimodality cancer therapyG D Demetri
Seminars in Oncology|August 1, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF): preclinical and clinical investigationsG D Demetri, K H Antman
Hematology/Oncology Clinics of North America|August 1, 1995
Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinicG D Demetri, A D Elias
Hematology/Oncology Clinics of North America|September 1, 1989
Hemopoietins and leukemiaG D Demetri, J D Griffin
Hematology/Oncology Clinics of North America|April 1, 1996
Chemotherapy and neutropeniaS K Kim, G D Demetri
Cancer|October 1, 1994
Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer. A case reportR Salgia, G D Demetri, W D Kaplan
Oncogene|June 5, 2007
KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathwayS Bauer, A Duensing, G D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study GroupG D Demetri, M Kris, J Wade, et al.
The Lancet. Oncology|March 22, 2002
Management of soft-tissue sarcomas: an overview and updateS Singer, G D Demetri, E H Baldini, et al.
The Journal of Biological Chemistry|April 5, 1989
Regulation of granulocyte- and monocyte-colony stimulating factor mRNA levels in human blood monocytes is mediated primarily at a post-transcriptional levelT J Ernst, A R Ritchie, G D Demetri, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Chest|June 1, 1995
Hematopoietic growth factors. Defining the appropriate clinical role in multimodality cancer therapyG D Demetri
Seminars in Oncology|August 1, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF): preclinical and clinical investigationsG D Demetri, K H Antman
Hematology/Oncology Clinics of North America|August 1, 1995
Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinicG D Demetri, A D Elias
Hematology/Oncology Clinics of North America|September 1, 1989
Hemopoietins and leukemiaG D Demetri, J D Griffin
Hematology/Oncology Clinics of North America|April 1, 1996
Chemotherapy and neutropeniaS K Kim, G D Demetri
Cancer|October 1, 1994
Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer. A case reportR Salgia, G D Demetri, W D Kaplan
Oncogene|June 5, 2007
KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathwayS Bauer, A Duensing, G D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study GroupG D Demetri, M Kris, J Wade, et al.
The Lancet. Oncology|March 22, 2002
Management of soft-tissue sarcomas: an overview and updateS Singer, G D Demetri, E H Baldini, et al.
The Journal of Biological Chemistry|April 5, 1989
Regulation of granulocyte- and monocyte-colony stimulating factor mRNA levels in human blood monocytes is mediated primarily at a post-transcriptional levelT J Ernst, A R Ritchie, G D Demetri, et al.
Pageof 7